Literature DB >> 21344495

Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ).

Matthew D Barber1, Zhen Chen, Emily Lukacz, Alayne Markland, Clifford Wai, Linda Brubaker, Ingrid Nygaard, Alison Weidner, Nancy K Janz, Cathie Spino.   

Abstract

AIMS: To evaluate validity and responsiveness of PFDI and PFIQ short forms across four multi-center studies and develop conversion formulas between short and long versions.
METHODS: 1,006 participants in four prospective studies of pelvic floor disorders completed long versions of the PFDI, PFIQ, and SF-36 (or SF-12) at baseline and 3 and 12 months after treatment. Responses were used to calculate scores for the short versions. We calculated correlations between scale versions using Pearson's correlation coefficient and compared their relative responsiveness using the standardized response mean.
RESULTS: PFDI and PFIQ short form scale scores demonstrated excellent correlations with long versions and similar responsiveness. Responsiveness was good to excellent for PFDI-20 urinary and prolapse scales, moderate for PFDI-20 colorectal scale and each of the PFIQ-7 scales, and poor for SF-36 (or SF-12) summary scores. Conversion formulas demonstrated excellent goodness of fit.
CONCLUSIONS: The long and short forms of the PFDI and PFIQ correlate well and have similar overall responsiveness in participants from four different prospective multicenter studies consisting of diverse patient populations with a broad range of pelvic floor disorders. The short forms provide a reliable and valid alternative in situations where reduced response burden is desired.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21344495      PMCID: PMC3759146          DOI: 10.1002/nau.20934

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  23 in total

1.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

2.  Validity and reliability of the Modified Manchester Health Questionnaire in assessing patients with fecal incontinence.

Authors:  Soo Kwon; Anthony G Visco; Mary P Fitzgerald; Wen Ye; William E Whitehead
Journal:  Dis Colon Rectum       Date:  2005-02       Impact factor: 4.585

3.  Reliability of health-related quality-of-life measures 1 year after surgical procedures for pelvic floor disorders.

Authors:  Patricia A Wren; Nancy K Janz; Linda Brubaker; Mary Pat Fitzgerald; Anne M Weber; Frankie B LaPorte; John T Wei
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

4.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

5.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

6.  Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma.

Authors:  T van der Molen; D S Postma; A J Schreurs; H E Bosveld; M R Sears; B Meyboom de Jong
Journal:  Qual Life Res       Date:  1997-05       Impact factor: 4.147

Review 7.  Generic versus disease-specific health status measures. An example using coronary artery disease and congestive heart failure patients.

Authors:  F D Wolinsky; K W Wyrwich; N A Nienaber; W M Tierney
Journal:  Eval Health Prof       Date:  1998-06       Impact factor: 2.651

8.  Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7).

Authors:  M D Barber; M D Walters; R C Bump
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

9.  Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?

Authors:  M Jolly; T O Utset
Journal:  Lupus       Date:  2004       Impact factor: 2.911

10.  Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: a randomized controlled trial.

Authors:  Patricia S Goode; Kathryn L Burgio; Julie L Locher; David L Roth; Mary G Umlauf; Holly E Richter; R Edward Varner; L Keith Lloyd
Journal:  JAMA       Date:  2003-07-16       Impact factor: 56.272

View more
  41 in total

1.  Longitudinal changes in symptom-based female and male LUTS clusters.

Authors:  Cindy L Amundsen; Margaret E Helmuth; Abigail R Smith; John O L DeLancey; Catherine S Bradley; Kathryn E Flynn; Kimberly S Kenton; H Henry Lai; David Cella; James W Griffith; Victor P Andreev; J Eric Jelovsek; Alice B Liu; Ziya Kirkali; Claire C Yang
Journal:  Neurourol Urodyn       Date:  2019-11-25       Impact factor: 2.696

Review 2.  Impact of fecal incontinence and its treatment on quality of life in women.

Authors:  Isuzu Meyer; Holly E Richter
Journal:  Womens Health (Lond)       Date:  2015-03

3.  Association between vaginal bulge and anatomical pelvic organ prolapse during pregnancy and postpartum: an observational study.

Authors:  Cathrine Reimers; Jette E Stær-Jensen; Franziska Siafarikas; Kari Bø; Marie Ellström Engh
Journal:  Int Urogynecol J       Date:  2017-07-11       Impact factor: 2.894

4.  Norwegian translation, and validation, of the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7).

Authors:  Catherine J Teig; Margreth Grotle; Malcolm J Bond; Cecilia A C Prinsen; Marie A Ellström Engh; Milada S Cvancarova; Møyfrid Kjøllesdal; Angelita Martini
Journal:  Int Urogynecol J       Date:  2017-01-06       Impact factor: 2.894

5.  Reliability and validity of the Japanese version of the pelvic floor distress inventory-short form 20.

Authors:  Mikako Yoshida; Ryoko Murayama; Erika Ota; Maki Nakata; Shiro Kozuma; Yukio Homma
Journal:  Int Urogynecol J       Date:  2012-10-19       Impact factor: 2.894

6.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.

Authors:  Kari Bo; Helena C Frawley; Bernard T Haylen; Yoram Abramov; Fernando G Almeida; Bary Berghmans; Maria Bortolini; Chantale Dumoulin; Mario Gomes; Doreen McClurg; Jane Meijlink; Elizabeth Shelly; Emanuel Trabuco; Carolina Walker; Amanda Wells
Journal:  Int Urogynecol J       Date:  2016-12-05       Impact factor: 2.894

7.  Relationship between the Pelvic Organ Prolapse Quantification system (POP-Q), the Pelvic Floor Impact Questionnaire (PFIQ-7), and the Pelvic Floor Distress Inventory (PFDI-20) before and after anterior vaginal wall prolapse surgery.

Authors:  P Teleman; E Laurikainen; I Kinne; R Pogosean; U Jakobsson; M Rudnicki
Journal:  Int Urogynecol J       Date:  2014-05-28       Impact factor: 2.894

8.  Conceptual framework for patient-important treatment outcomes for pelvic organ prolapse.

Authors:  Vivian W Sung; Rebecca G Rogers; Matthew D Barber; Melissa A Clark
Journal:  Neurourol Urodyn       Date:  2013-03-13       Impact factor: 2.696

9.  Baseline Lower Urinary Tract Symptoms in Patients Enrolled in LURN: A Prospective, Observational Cohort Study.

Authors:  Anne P Cameron; Christina Lewicky-Gaupp; Abigail R Smith; Brian T Helfand; John L Gore; J Quentin Clemens; Claire C Yang; Nazema Y Siddiqui; H Henry Lai; James W Griffith; Victor P Andreev; Gang Liu; Kevin Weinfurt; Cindy L Amundsen; Catherine S Bradley; John W Kusek; Ziya Kirkali
Journal:  J Urol       Date:  2017-10-28       Impact factor: 7.450

10.  Does a history of bullying and abuse predict lower urinary tract symptoms, chronic pain, and sexual dysfunction?

Authors:  Tori Nault; Priyanka Gupta; Michael Ehlert; Emily Dove-Medows; Marlene Seltzer; Donna J Carrico; Jason Gilleran; Jamie Bartley; Kenneth M Peters; Larry Sirls
Journal:  Int Urol Nephrol       Date:  2016-08-05       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.